Show simple item record

dc.contributor.authorClayton, B
dc.contributor.authorBall, S
dc.contributor.authorRead, J
dc.contributor.authorWaddy, S
dc.date.accessioned2023-02-20T12:02:59Z
dc.date.available2023-02-20T12:02:59Z
dc.date.issued2018-08
dc.identifier.issn1470-2118
dc.identifier.issn1473-4893
dc.identifier.urihttp://hdl.handle.net/10026.1/20456
dc.description.abstract

Although common, the long-term significance of -developing atrial fibrillation (AF) during a period of critical illness is unclear. We undertook a retrospective cohort analysis to -assess the rate of thromboembolism (TE) in patients -developing atrial fibrillation de novo during admission to our intensive care unit. In total, 1,955 patients were followed up (-maximum follow-up 1,276 days) for the occurrence of TE, of which 220 (11.3%) had developed AF or atrial flutter during their critical care admission. There were 11 TE events among the patients with new AF (0.053 events per patient-year), compared with 18 in the non-AF group (0.0059 events per patient-year). The unadjusted hazard ratio for TE in patients developing new AF compared with those not developing AF was 8.09 (95% CI 3.08-17.19, p<0.001). In patients admitted to critical care, the development of AF appears to be associated with a significantly increased risk of subsequent thromboembolism.

dc.format.extent282-287
dc.format.mediumPrint
dc.languageen
dc.language.isoeng
dc.publisherRoyal College of Physicians
dc.subjectAtrial fibrillation
dc.subjectcritical care
dc.subjectcritical illness
dc.subjectintensive care
dc.subjectstroke
dc.subjectthromboembolism
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectAtrial Fibrillation
dc.subjectCritical Illness
dc.subjectFemale
dc.subjectHumans
dc.subjectKaplan-Meier Estimate
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectRetrospective Studies
dc.subjectRisk Factors
dc.subjectStroke
dc.subjectThromboembolism
dc.subjectUnited Kingdom
dc.titleRisk of thromboembolism in patients developing critical illness-associated atrial fibrillation
dc.typejournal-article
dc.typeJournal Article
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/30072549
plymouth.issue4
plymouth.volume18
plymouth.publication-statusPublished
plymouth.journalClinical Medicine
dc.identifier.doi10.7861/clinmedicine.18-4-282
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
plymouth.organisational-group/Plymouth/Users by role/Post-Graduate Research Students
dc.publisher.placeEngland
dcterms.dateAccepted2018-01-01
dc.rights.embargodate2023-2-23
dc.identifier.eissn1473-4893
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.7861/clinmedicine.18-4-282
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV